{"id":476,"date":"2026-08-28T06:56:06","date_gmt":"2026-08-28T06:56:06","guid":{"rendered":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/"},"modified":"2026-09-01T09:40:18","modified_gmt":"2026-09-01T09:40:18","slug":"aod-9604-options-trial-null-weight-loss-result","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/es\/aod-9604-options-trial-null-weight-loss-result\/","title":{"rendered":"Estudio AOD-9604 OPTIONS: resultado primario, resultado nulo y l\u00edmites de evidencia"},"content":{"rendered":"
AOD-9604 avanz\u00f3 m\u00e1s all\u00e1 del trabajo con animales y se convirti\u00f3 en un programa de desarrollo de la obesidad. La revisi\u00f3n 2024 de FDA registra que el gran estudio OPTIONS no mostr\u00f3 una p\u00e9rdida de peso estad\u00edsticamente significativa en comparaci\u00f3n con el placebo y que se interrumpi\u00f3 el desarrollo de la obesidad.<\/p>
Lo que muestra el registro<\/h2>
El informe FDA registra a los participantes inscritos en 536 y aleatorizados a 502; una figura del patrocinador reproducida tiene la etiqueta \"Todos los datos N=503\".<\/li>
La p\u00e9rdida de peso versus placebo en las semanas 12 y 24 fue demasiado peque\u00f1a para alcanzar significaci\u00f3n estad\u00edstica.<\/li>
FDA no pudo localizar una publicaci\u00f3n completa de una revista m\u00e9dica con los m\u00e9todos del estudio y los detalles preliminares de eficacia.<\/li><\/ul><\/div><\/div>Ilustraci\u00f3n editorial original del contexto de la investigaci\u00f3n. No es una figura de estudio, una imagen de un paciente, una fotograf\u00eda del producto suministrado ni una representaci\u00f3n de material de prueba.<\/figcaption><\/figure>
Registro de estudio<\/h2>
El informe FDA cita la conclusi\u00f3n del patrocinador de que la poblaci\u00f3n del estudio m\u00e1s amplia no respondi\u00f3 de manera consistente y que el resultado no apoy\u00f3 el desarrollo de la obesidad comercial. Este historial negativo tiene m\u00e1s peso que las primeras se\u00f1ales aisladas.<\/p>
Programa<\/strong>Estudio de desarrollo de obesidad de fase IIb OPTIONS<\/span><\/div>
Inscrito<\/strong>Participantes de 536<\/span><\/div>
Aleatorizado<\/strong>Participantes de 502 en la narrativa FDA<\/span><\/div>
Etiqueta de figura del patrocinador<\/strong>Todos los datos, N=503; reproducido en el informe FDA<\/span><\/div>
Interpretaci\u00f3n primaria<\/strong>No hay una separaci\u00f3n estad\u00edsticamente significativa entre la p\u00e9rdida de peso y el placebo<\/span><\/div>
Resultado de desarrollo<\/strong>Finalizado el programa de obesidad<\/span><\/div><\/div><\/div>
Resultados en contexto<\/h2>
La brecha de publicaci\u00f3n es importante. Sin un informe completo revisado por pares, los lectores no pueden inspeccionar de forma independiente todos los an\u00e1lisis preespecificados, el manejo de los datos faltantes y las decisiones de los subgrupos.<\/p>
Por lo tanto, AOD-9604 debe describirse como un fragmento de investigaci\u00f3n de GH con un criterio de valoraci\u00f3n fallido de desarrollo de obesidad, no como un \u201cp\u00e9ptido quemagrasas\u201d cl\u00ednicamente probado.<\/p>
Lo que este estudio no puede responder<\/h2>
Los detalles m\u00e1s importantes de los ensayos a gran escala se encuentran en los registros regulatorios y de la empresa, en lugar de en un informe completo del ensayo revisado por pares.<\/p>
El fracaso en el desarrollo de la obesidad no responde a todas las preguntas de laboratorio, pero contradice directamente las afirmaciones humanas seguras sobre la p\u00e9rdida de peso.<\/p>","protected":false},"excerpt":{"rendered":"
AOD-9604 avanz\u00f3 m\u00e1s all\u00e1 del trabajo con animales y se convirti\u00f3 en un programa de desarrollo de la obesidad. La revisi\u00f3n 2024 de FDA registra que el gran estudio OPTIONS no mostr\u00f3 una p\u00e9rdida de peso estad\u00edsticamente significativa en comparaci\u00f3n con el placebo y que se interrumpi\u00f3 el desarrollo de la obesidad.<\/p>","protected":false},"author":1,"featured_media":641,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"314","pim_article_type":"Published study case","pim_evidence_level":"FDA-reviewed development record; pivotal result not published as a full journal trial","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"Source-checked on 2026-08-28. Null findings and study limitations are retained. This is not independent peer review, medical advice, a customer case, or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"FDA December 2024 AOD-9604 briefing document\",\"url\":\"https:\/\/www.fda.gov\/media\/183584\/download\",\"note\":\"FDA review of effectiveness, safety and the OPTIONS result.\"},{\"title\":\"AOD-9604 development review\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15134286\/\",\"note\":\"Contemporaneous development summary; PMID 15134286.\"},{\"title\":\"FDA December 2024 PCAC meeting record\",\"url\":\"https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/updated-meeting-time-and-public-participation-information-december-4-2024-meeting-pharmacy\",\"note\":\"Regulatory meeting context.\"}]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-476","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"\n
AOD-9604 OPTIONS Study: Primary Outcome, Null Result and Evidence Limits - NHD<\/title>\n<meta name=\"description\" content=\"AOD-9604 progressed beyond animal work into an obesity-development program. FDA\u2019s 2024 review records that the large OPTIONS study did not show statistical\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/es\/aod-9604-options-trial-null-weight-loss-result\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AOD-9604 OPTIONS Study: Primary Outcome, Null Result and Evidence Limits\" \/>\n<meta property=\"og:description\" content=\"AOD-9604 progressed beyond animal work into an obesity-development program. FDA\u2019s 2024 review records that the large OPTIONS study did not show statistical\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/es\/aod-9604-options-trial-null-weight-loss-result\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T06:56:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-01T09:40:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"AOD-9604 OPTIONS Study: Primary Outcome, Null Result and Evidence Limits\",\"datePublished\":\"2026-08-28T06:56:06+00:00\",\"dateModified\":\"2026-09-01T09:40:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/\"},\"wordCount\":283,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/\",\"name\":\"AOD-9604 OPTIONS Study: Primary Outcome, Null Result and Evidence Limits - NHD\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp\",\"datePublished\":\"2026-08-28T06:56:06+00:00\",\"dateModified\":\"2026-09-01T09:40:18+00:00\",\"description\":\"AOD-9604 progressed beyond animal work into an obesity-development program. FDA\u2019s 2024 review records that the large OPTIONS study did not show statistical\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/aod-9604-options-trial-null-weight-loss-result\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AOD-9604 OPTIONS Study: Primary Outcome, Null Result and Evidence Limits\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/es\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Estudio AOD-9604 OPTIONS: resultado primario, resultado nulo y l\u00edmites de evidencia - NHD","description":"AOD-9604 avanz\u00f3 m\u00e1s all\u00e1 del trabajo con animales y se convirti\u00f3 en un programa de desarrollo de la obesidad. La revisi\u00f3n 2024 de FDA registra que el gran estudio OPTIONS no mostr\u00f3 estad\u00edsticas...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/es\/aod-9604-options-trial-null-weight-loss-result\/","og_locale":"es_ES","og_type":"article","og_title":"AOD-9604 OPTIONS Study: Primary Outcome, Null Result and Evidence Limits","og_description":"AOD-9604 progressed beyond animal work into an obesity-development program. FDA\u2019s 2024 review records that the large OPTIONS study did not show statistical\u2026","og_url":"https:\/\/nhdbio.com\/es\/aod-9604-options-trial-null-weight-loss-result\/","og_site_name":"NHD","article_published_time":"2026-08-28T06:56:06+00:00","article_modified_time":"2026-09-01T09:40:18+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"AOD-9604 OPTIONS Study: Primary Outcome, Null Result and Evidence Limits","datePublished":"2026-08-28T06:56:06+00:00","dateModified":"2026-09-01T09:40:18+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/"},"wordCount":283,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp","articleSection":["Published Study Reviews"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/","url":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/","name":"Estudio AOD-9604 OPTIONS: resultado primario, resultado nulo y l\u00edmites de evidencia - NHD","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp","datePublished":"2026-08-28T06:56:06+00:00","dateModified":"2026-09-01T09:40:18+00:00","description":"AOD-9604 avanz\u00f3 m\u00e1s all\u00e1 del trabajo con animales y se convirti\u00f3 en un programa de desarrollo de la obesidad. La revisi\u00f3n 2024 de FDA registra que el gran estudio OPTIONS no mostr\u00f3 estad\u00edsticas...","breadcrumb":{"@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/aod-9604-options-trial-null-weight-loss-result-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/aod-9604-options-trial-null-weight-loss-result\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"AOD-9604 OPTIONS Study: Primary Outcome, Null Result and Evidence Limits"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Materias primas pept\u00eddicas y s\u00edntesis personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipo t\u00e9cnico de NHD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"El equipo t\u00e9cnico de NHD mantiene documentaci\u00f3n del cat\u00e1logo de uso de investigaci\u00f3n y res\u00famenes de evidencia. Los art\u00edculos revisados \u200b\u200benlazan con art\u00edculos revisados \u200b\u200bpor pares, registros de ensayos y registros regulatorios, conservan hallazgos nulos y limitaciones de estudios, y distinguen las intervenciones publicadas de los materiales del cat\u00e1logo. Se puede utilizar dibujo asistido por AI para la estructura; los enlaces de fuentes y los l\u00edmites de las pruebas permanecen visibles. Este trabajo no es una revisi\u00f3n por pares independiente ni un consejo m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/es\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/476","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/comments?post=476"}],"version-history":[{"count":3,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/476\/revisions"}],"predecessor-version":[{"id":713,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/476\/revisions\/713"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media\/641"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media?parent=476"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/categories?post=476"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/tags?post=476"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"Cient\u00edfico](\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828.png\")